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Editorial 
Suicide research, prevention and Covid-19: towards a global response and the 
establishment of an international research collaboration  
Niederkrotenthaler T,* Gunnell D,* Arensman E,* Pirkis J ,* Appleby L** Hawton K,** John A,** 
Kapur N,** Khan M,** O’Connor RC** Platt S,** and the International COVID-19 Suicide Prevention 
Research Collaboration 






In response to concerns about the impact of the Covid-19 pandemic on the incidence of suicide and 
suicidal behaviors, the International Covid-19 Suicide Prevention Research Collaboration (ICSPRC) – 
came together to identify key priorities for suicide prevention. In this Editorial we now highlight the 
existing knowledge gaps concerning the epidemiology of suicide and suicidal behavior and the 
effectiveness of intervention and prevention measures during Covid-19 which underline the need for 
a strategic approach to suicide research and prevention at global level.  We then identify research 
and funding priorities for 1) population-based research and high-risk groups and the impact of Covid-
19 on suicide, and 2) interventions to mitigate the risk of suicidal behavior associated with the 
pandemic. In a challenging economic environment, suicide researchers will need to strongly advocate 
for the importance of the issues identified and make sure the research that is conducted is of the 
highest possible quality and ethical standards to inform public health, policy and health care 








The Covid-19 pandemic of 2020 is a major global health challenge. At the time of writing over 8.0 
million people around the world had been registered as infected and 436,000 as died 
(Worldometers, 2020, accessed 15 June 2020).  Public health responses to Covid-19 need to balance 
direct efforts to control the disease and its impact on health systems, infected people and their 
families, with the impacts from associated mitigating interventions. Such impacts include social 
isolation, quarantine, school closure, health service disruption stemming from refiguring health 
systems and diminished economic activity.  The primary focus of both the United Nations (UN) and 
the World Health Organization (WHO) has been on addressing Covid-19 as a physical health crisis, 
but the need to strengthen mental health action, including suicide prevention, is increasingly 
recognized, as is the need for mental health research to be an integral part of the recovery plan 
(United Nations, 2020a). The impacts of the pandemic on physical and mental health will unfold 
differently over time and vary depending on the duration and fluctuating intensity of the disease. 
Research is needed to help ensure that decision making regarding all aspects of health, including 
mental health (Holmes et al 2020), is informed by the best quality data at each stage of the 
pandemic. 
 
The pandemic poses a prolonged and unique challenge to public mental health, with major 
implications for suicide and suicide prevention (Gunnell et al, 2020; Reger et al, 2020). A rise in 
suicide deaths in the wake of the pandemic is not inevitable. There is consensus, however, that the 
mitigation of risk will be contingent upon a proactive and effective response involving collaborative 
working between the State, NGOs, academia, and local governments and coordinated leadership 
across government ministries, including health, education, security, social services, welfare and 
finance. Countries have responded in a variety of different ways to the pandemic, effectively creating 
a series of natural experiments. Thus, regions of the world affected later in the pandemic can draw 
on lessons from countries, such as China and Italy, affected in its early phase. Likewise, lessons learnt 
early in the pandemic (e.g. on the impact of lock down and physical distancing measures), can be 
used to inform responses to any future surges in incidence of Covid-19. 
 
Although there are important parallels between countries in the course of the pandemic and related 
responses, some stressors, responses and priorities are likely to differ between high and low-middle 
income countries and between cultures and regions. As Covid-19 appears to be disproportionately 
affecting Black, Asian and Minority Ethnic communities, the response, and suicide prevention 
research carried out to inform the response, needs to be sufficiently granular and account for the 
complexity of risks in these groups (O’Connor et al., 2020). 
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Throughout this Editorial, when we refer to suicide and suicidal behavior, we mean to include both 
fatal and non-fatal suicidal behaviors and self-harm. 
 
The need for evidence-based suicide prevention responses 
 
Suicide is the most extreme outcome of a mental health crisis and should therefore be a key priority 
in any broader mental health response to the pandemic (Gunnell et al, 2020; Reger et al, 2020). 
Suicide prevention responses need to be informed by research that is as specific as possible to the 
current situation and takes account of the many mechanisms that have an impact on suicide, as they 
may vary during the different phases of the pandemic.  At the same time, given the risks involved, 
strategic development of policy and implementation responses cannot wait until all aspects of the 
epidemiology and consequences of the disease on mental health and risk of suicide are understood.  
 
The dilemma here is that few studies have investigated the impact of previous pandemics – or even 
epidemics – on suicide (Wasserman 1992; Cheung et al. 2008; Zortea et al., 2020), and none has 
evaluated suicide prevention measures in the current context. An analysis of the impact of the 
Spanish Flu epidemic (1918-20) in the USA indicated that it resulted in a small rise in suicides 
(Wasserman 1992). Cheung and colleagues (2008) reported a rise in suicide amongst older people 
during the 2003 SARS epidemic in Hong Kong. Similarly, what can be learned from other types of 
public health emergencies is limited. Much of the related research comes from one-off events, such 
as terrorist attacks and natural disasters (e.g. earthquakes). Findings from such events might not be 
applicable to the current situation (Devitt, 2020). 
 
Early research findings relevant to assessing the impact of Covid-19 on mental health 
Early publications relevant to the Covid-19 response have largely come from small selective surveys 
or case reports, often using indirect measures of suicide risk or from modeling approaches to predict 
the impact of the pandemic. These have addressed issues such as the impact of quarantine (Brooks 
et al, 2020), highlighted possible high-risk groups (Yao et al 2020), and assessed mental health 
service disruption (Royal College of Psychiatrists 2020).  
 
Physical distancing and related measures, which have been at the forefront of the public health 
response, carry a strong risk of increasing isolation, particularly in vulnerable populations such as 
older people and people who have been bereaved (Yip & Chau 2020; De Leo & Trabucchi, 2020; 
Wand et al., 2020; Brooks et al, 2020). Physical distancing measures may also lead to increases in 
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household stress levels, domestic violence and alcohol misuse and affect the accessibility of mental 
health services (Reger et al, 2020; Brooks et al, 2020). The stresses of lockdown may be worse in low- 
and middle-income countries where extended families tend to live together with limited housing 
space.  
 
Concerns have been expressed about subsequent increases in demand for psychiatric emergency 
care (Royal College of Psychiatrists, 2020). In the context of overwhelmed healthcare systems and 
shortages of resources to treat people with Covid-19 in healthcare settings, qualitative findings from 
China indicate that the intensity of work during the pandemic drained healthcare workers physically 
and emotionally (Liu et al, 2020). In the UK the British Medical Association’s wellbeing support 
services have seen a 40% increase in use after the onset of the pandemic (Torjesen, 2020).  
 
Positive effects of the pandemic on the public, such as increased pro-social behavior (e.g., donating 
and volunteering) and the strengthening of community ties may help to mitigate detrimental impacts 
of physical distancing (Van Bavel et al, 2020). The move of some health and third sector services into 
online settings may also have long-lasting benefits in improving service accessibility, particularly to 
those who find face-to-face consultation difficult. The effect on people with mental illness of 
replacing face-to-face treatment with remote delivery of care, however, remains unclear. Moreover, 
in low- and middle-income countries the technology to support remote assessment is limited (De 
Sousa et al, 2020, United Nations 2020a). In these, and other settings, where there is limited access 
to specialist mental health services, community and peer support becomes extremely important.  
 
In the longer term, the potential for the Covid-19 virus to affect the brain and to cause long-lasting 
physical morbidity means it might become relevant as a risk factor for mental illness and suicide in 
the future (Wu et al 2020; Holmes et al, 2020; Rogers et al, 2020). Review findings indicate that the 
incidence of psychosis, a major risk factor for suicide and suicidal behavior, appeared to be high in 
people following SARS, MERS and H1N1 infection (Rogers et al., 2020). Given emerging evidence that 
the virus can have severe effects on different organ systems including kidney and liver function 
(Zhang et al., 2020) physical consequences of infections might include a prolonged reduction in 
functional capacity and disability in some patients, all of which might have potential implications for 
suicide risk and prevention.  
 
However, longer-term risks for suicide are likely most closely related to the economic consequences 
of the pandemic, including financial strain and unemployment. In a study based on suicide data from 
54 countries, the recession of 2008 was associated with a 3.3% increase in suicides in men (but not 
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women) in the following year and more prolonged increases in several countries (Chang et al., 2013). 
The increase varied depending on the regional depth of the recession, and specifics of social 
insurance systems (e.g., regulations for unemployment benefits or payed sick leave) (Chang et al, 
2013; Norström 2014). The economic downturn associated with the Covid-19 pandemic may be more 
rapid in onset than the 2008 recession and may push an estimated 500 million people, particularly in 
low- and middle-income countries, below the poverty line (United Nations, 2020b).   
  
Early research findings relevant to assessing the impact of Covid-19 on suicide and suicidal 
behavior 
There is, as yet, no direct evidence of the impact of the pandemic on suicidal behavior. While a 
number of news stories from Japan, New Zealand and Germany report a decrease in suicides in the 
period around the time of lockdown (The Guardian, 2020; New Zealand Herald, 2020; Deutsche 
Welle 2020), these are all based on preliminary data / anecdotal reports and unsubstantiated by peer 
reviewed publications. General population survey findings from the UK have shown no clear 
evidence of a rise in reported self-harm during the weeks following lockdown (after March 23rd), but 
no-pre-lockdown data are available (Fancourt et al, 2020). Many surveys have been carried out in the 
wake of the pandemic, many of these use convenience samples, which are prone to selection bias 
(Pierce et al, 2020). In addition, there have been multiple case reports from some low and middle 
income countries highlighting occurrences of suicide thought to be related to Covid-19 (Mamum  & 
Ullah, 2020; De Sousa et al, 2020).  These reports must, however, be interpreted with great caution - 
and even more so when these are based on mass media reports, which are unlikely to have been 
validated.    
 
Some researchers have attempted to model the possible pandemic-associated increase in suicides, 
largely based on predicted rises in unemployment (Kawohl & Nordt, 2020; Moser et al 2020; 
McIntyre & Lee 2020). Risk estimates vary widely, from a 1% increase in global suicides (Kawohl & 
Nordt, 2020) to a doubling of national suicides in a Swiss study, using prison incarceration as a  
questionable proxy for modeling the social distancing effects of lockdown (Moser et al, 2020). These 
discrepancies are partly due to differences in modelling assumptions, which are associated with 
considerable uncertainty and may be very misleading. Given the methodological limitations, the 
uncertainty of the baseline assumptions and how events will subsequently unfold, as well as the 
unprecedented aspects of the Covid-19 pandemic, the results of these tentative projections can at 
best provide a guide as to where action should be directed but are largely unhelpful in accurate 
quantifications of future suicidal behavior and suicide. In this regard, access to real-time suicide 
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mortality data is a key priority (Gunnell et al, 2020). Further, active surveillance systems for suicide 
attempts are warranted (WHO, 2016). 
 
In the absence of direct evidence of trends in suicide, some researchers have used search behavior 
on Google Trends for terms related to suicide, as a proxy for suicide risk (Sinyor et al, in press, Knipe 
et al, 2020). Their findings indicate that, although relative search volumes for financial and work-
related concerns have increased (Knipe et al, 2020), searches for suicide and suicide methods have 
not (Sinyor et al, in press, Knipe et al, 2020). The potential limitations of Google search data for 
surveillance are well recognized and include little knowledge on algorithms used, and issues with the 
stability of findings provided by Google Trends, as well of inconsistent associations with suicide (Tran 
et al 2017). 
 
The existing knowledge gaps concerning the epidemiology of suicide and suicidal behavior during 
Covid-19 and the effectiveness of intervention and prevention measures, underline the need for a 
strategic approach to suicide research and prevention at a global level.  The uncertainties regarding 
the direct and indirect effects of Covid-19 on suicide, can only be addressed with good-quality 
tailored research. Furthermore, suicide prevention in the age of Covid-19 needs to build on what we 
know about the effectiveness of various measures, but also needs to take account of the unique 
challenges posed by the situation in order to develop novel approaches. Our knowledge is currently 
still very limited and building the evidence base on suicide prevention is crucial.  
 
 
Research considerations during Covid-19 
There are several considerations in relation to suicide prevention research carried out during crisis 
situations and in the present global pandemic (Box 1). These include ensuring the safety of research 
participants and researchers as well as the need for research to focus on low and middle-income 
settings as well as high income countries, remembering that findings from one setting may not 
generalize to another.  We expand on a few specific issues in the following section. First, the limited 
research conducted thus far on suicide and its prevention during Covid-19 has focused mostly on 
high income countries. Whilst complementary research in this area in low and middle income 
countries should be prioritized, the poor quality of routine mortality and hospital attendance data as 
well as the limited availability of resources to carry out research in many of these settings present 
very real challenges. In 2014 the WHO considered that just over one third of member states had 
good-quality suicide registration data, and such data were largely absent in low and-middle income 
7 
countries (WHO, 2014). The establishment of sentinel sites to gather as accurate data on suicidal 
behavior as possible to supplement those that already exist would be one way forward (WHO, 2016).  
 
Second, as a result of the pandemic, mental health services have had to develop new ways of 
working to deliver care to suicidal individuals, including new care pathways, the mass roll-out of 
remote consultation and increased use of digital interventions.  These new ways of working require 
real-time evaluation and ongoing adaptation in response to findings; traditional evaluation 
approaches, such as randomized trials, may need to be adapted in a manner that is still consistent 
with making robust inferences about their effectiveness. 
 
Third, with school and university closures in place in a number of countries, the traditional setting for 
carrying out research into children and young people’s health is no longer available. Given current 
concerns about the impact of the pandemic on young people, mental health researchers will need to 
find alternative routes to studying the impact of the pandemic on this potentially vulnerable group.  
 
Fourth, for all studies it is vital that those with lived experience of suicide are involved in shaping the 
research at all stages - from developing the research questions to data collection and dissemination 
of the findings. Fifth, all research needs to comply with ethical standards. Researchers who are not 
normally working in the area of mental health and suicide prevention but who are now shaping 
conversations on suicide prevention need to obtain necessary training and background information 
on how to conduct suicide research, including the need to follow established research protocols and 
safety considerations that are specific to the field (Townsend et al 2020).  Sixth, it is important that 
research resources (i.e., staff, funding) are rapidly mobilized to ensure timely research evidence is 
available. However, this presents tensions between the time researchers have available to write 
robust funding applications, time-scales for the grant review by funding bodies and, if funded, the 
availability of high-quality fieldworkers and analysts as these are likely to be already committed to 
other projects. Flexibility and clear communication with funders about project delays and re-
allocation of resources should help ameliorate these challenges. There is a distinct possibility that 
research funding may be adversely affected by a post-pandemic recession. Seventh, any proposed 
research should have a clear pathway to impact to ensure that relevant clinicians and policy makers 
can implement the findings of research in their work. 
 
Lastly, traditional models of research publication, with the need for peer-review, introduce delays 
between article submission and on-line publication, reducing the speed with which evidence is 
disseminated and recommendations implemented. One solution is the fast track review processes 
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for selected papers – these were already in place before Covid-19, but have been extended and 
adopted by more journals since the beginning of the outbreak. Another solution is open science 
publication models that involve on-line publication of articles whilst they await peer review, although 
there is a danger of low-quality research findings being disseminated and acted upon precipitously, 
without scrutiny of their validity (Armstrong, 2020). In order to mitigate this risk, researchers need to 
take caution in labelling their findings as preliminary, and should implement a communications 
strategy that addresses the preliminary nature of findings.  
 
The International Covid-19 suicide prevention research collaboration (ICSPRC) 
High-quality timely research to understand the suicide-related consequences of Covid-19 and to 
determine how best to mitigate the risk stemming from these consequences is now needed. The 
United Nations highlights the need for “rapid knowledge acquisition”, establishing research priorities, 
coordinating research efforts, open-data sharing and funding (United Nations 2020a).  In response to 
widespread concerns about the impact of the Covid-19 pandemic on suicide and suicidal behavior, a 
group, initially consisting of 44 suicide prevention researchers and leaders of suicide prevention 
charities from around 20 countries, came together to pool their expertise about the likely impact of 
the pandemic on suicidal behavior and to identify prevention priorities. The “International Covid-19 
Suicide Prevention Research Collaboration” (ICSPRC) sought to include at least one representative 
from many of the most affected countries and also representation from high-, middle- and low-
income countries (https://www.iasp.info/COVID-19_suicide_research.php). The Collaboration’s 
assessment of the risks posed by the pandemic and suggested responses to mitigate these were 
summarized in a Lancet Psychiatry commentary published in April 2020 (Gunnell, Appleby, Arensman 
et al 2020).  
Building on this initiative, the collaborative network has extended to include suicide researchers from 
a wider range of countries (including countries in Africa, the Middle East and South America), with 
skills ranging from population health to biological psychiatry and incorporating expertise in 
quantitative and qualitative methods, together with ethics. The objectives of the group are to: 
a) Share early findings (and, where appropriate, data) on the impact of the pandemic, and the 
public health measures (e.g. physical distancing) to contain its spread, on suicidal behavior in 
participants’ countries and to provide timely policy advice to those in other countries. 
b) Facilitate collaboration / avoid duplication through sharing information about ongoing 
research studies and Covid-19 research tools / questionnaires focused on suicide prevention, 
as well as advice about study design.   
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c) Harmonize data collection approaches to facilitate pooling of data, where possible, from 
different settings and contexts. 
An early example of the success of this approach has been collaboration between two groups 
working on almost identical systematic reviews investigating the impact of pandemics/epidemics on 
suicide, self-harm and suicidal ideation (Zortea et al, 2020). Another group has established real-time 
surveillance of the emerging literature on Covid-19 and suicide to become a “living review” (John et 
al 2020). The global distribution of group members will facilitate rapid combined efforts in response 
to funding opportunities, where cross-national studies would strengthen the evidence base.  
Conducting high quality suicide prevention research is challenging. Suicide, in population terms, is a 
low incidence event and so studies are often under-powered to identify small, but potentially 
important effects. Furthermore, a focus on intermediate or proxy outcomes (e.g., self-reported 
suicidal ideation) is sometimes necessary but these have a questionable relationship to suicidal 
behaviors (May & Klonsky 2012; Mars et al 2019). The collaboration provides a mechanism to work 
together, pool data using shared protocols and investigate different outcomes with a range of 
research designs. It should also facilitate reaching global consensus on issues such as the impact of 
lockdown on suicide risk and how best to mitigate risk, especially if further periods are be required to 
address re-emergence of Covid-19, as has recently been reported in countries such as Iran 
(Worldometers 2020).   
The collaboration has identified several suggestions for research to help inform responses to the 
current and future pandemics, formulating these as research questions (see Boxes 2 and 3). The 
proposed research questions link to the gaps in knowledge that we identified above. Box 2 highlights 
research questions relating to whether rates of suicidal behavior increase as a result of the pandemic 
and what mechanisms may be driving any increase, suggesting specific research for the general 
population and for high-risk groups. Box 3 presents research questions relating to whether particular 
responses might help to mitigate any risk of suicide associated with the pandemic. Members of the 
collaboration have worked with the International Association for Suicide Prevention (IASP) to 
establish a searchable on-line list of ongoing Covid-relevant studies on suicidal behavior, managing 
suicidal crises and suicide prevention (https://www.iasp.info/covid-19/covid-19-suicide-research-
studies) to facilitate collaboration and avoid duplication, similar to the website developed for 
longitudinal studies on mental health during Covid-19  
(https://www.covidminds.org/longitudinalstudies). The role of IASP, in collaboration with other 
international and national organizations (e.g. World Health Organization (WHO), International 
Association of Suicide Research (IASR), American Foundation for Suicide Prevention (AFSP) and 
others), is to provide up-to-date information on suicide research and prevention in its global 
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network. IASP is developing a strategic plan to reduce Covid-19-related suicidal behavior and building 
a central pool of resources (expertise, research, guidelines for good practice, briefings) which will be 
available to support organizations globally (IASP, 2020 a, b). Members of the ICSPRC have 
contributed to a IASP briefing paper on reporting suicide during the Covid-19 pandemic and IASP 
members have developed guidance to help workplaces and professional associations through the 
Covid-19 Crisis (IASP 2020a and b).  The combination of the specific research focus in the ICSPRC and 
IASP, with its prevention network and links to WHO, as the leading organization for suicide 
prevention globally, is a core strength of this collaboration, and many members are active in both.  
A key issue the group needs to consider is how best to ensure the rapid dissemination of research 
and surveillance information to inform policy making and prevention activities. Furthermore, there is 
a need to consider the best way of responding to (sometimes unsubstantiated) findings reported in 
news articles which may be hastily picked up by policy makers and politicians. Three sorts of 
information are relevant: i) routinely available data (e.g. national mortality / survey data / research 
publications) that not everyone will be aware of – this could be disseminated via regular briefings / 
updates; ii) pre-publication research data and findings that may inform policy, but are going through 
peer review – one possible approach to sharing these data is via regular webinars / research 
presentations; and  iii) highly sensitive surveillance data e.g. known only to Government officials and 
individuals on national suicide prevention strategy groups who have agreed not to disclose them. The 
latter data are unlikely to be shareable, but it will be important to consider approaches to share 
broad findings to give those working in different settings the opportunity to act pre-emptively and 
before local data are available.  
Facilities for sharing data/measures/protocols/pre peer-reviewed manuscripts (e.g., the Open 
Science Framework and PsyArXiv) are possible options to build a repository of research that can have 
a digital object identifier (DOI), so are traceable and citable. Crisis now also publishes Registered 
Reports, which allow authors to submit research protocols for review before the research is 
conducted.  
Conclusion 
The unique challenges posed by the current pandemic requires suicide researchers to collaborate in 
order to understand the impact of Covid-19 on suicide and suicidal behavior and effective ways of 
mitigating the risk. We urge colleagues to complete the recently launched register of suicide 
prevention research studies to facilitate this [link again]. In a challenging economic environment, 
suicide researchers will need to advocate strongly for the importance of the issues we have identified 
and make sure the research that is conducted is of the highest possible quality and ethical standard 
to inform public health, policy and health care responses. Lessons learned and subsequent changes 
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made will contribute to improving response plans for future possible waves in this pandemic and 
other future pandemics. The establishment of the International Covid-19 Suicide Prevention 
Research Collaboration is an important contribution to this effort and we ask suicide researchers 
particularly from regions currently not represented to join us. 
 
 
International Covid-19 Suicide Prevention Research Collaboration (ICSPRC) group members: Pablo 
Analuisa Aguilar, Louis Appleby, Ella Arensman, Jose Luis Ayuso, Jason Bantjes, Jose Bertolote, Eric 
Caine, Lai Fong Chan, Shu-Sen Chang, Ying-Yeh Chen, Helen Christensen, Rakhi Dandona, Diego De 
Leo, Michael Eddleston, Annette Erlangsen, David Gunnell, Jill Harkavy-Friedman, Keith Hawton, 
Kristin Holland, Ann John, Fabrice Jollant, Nav Kapur, Murad Khan, Olivia J Kirtley, Duleeka Knipe, 
Kairi Kolves, Flemming Konradsen, Shiwei Liu, Sally McManus, Lars Mehlum, Matt Miller, Ellenor 
Mittendorfer-Rutz, Paul Moran, Jacqui Morrissey, Christine Moutier, Thomas Niederkrotenthaler, 
Emma Nielsen, Merete Nordentoft, Rory O’Connor, Siobhan O’Neill, Joseph Osafo, Maria Oquendo, 
Andrew Page, Michael Phillips, Jane Pirkis, Steve Platt, Boris Polozhy, Maurizio Pompili, Ping Qin, 
Thilini Rajapakse, Mohsen Rezaeian, Barbara Schneider, Morton M Silverman, Mark Sinyor, Steven 




Armstrong S. Research on covid-19 is suffering “imperfect incentives at every stage” BMJ 2020; 369 
doi: https://doi.org/10.1136/bmj.m2045 (Published 28 May 2020) 
 
Brooks, SK, Webster, RK, Smith, LE, Woodland, L, Wessely, S, Greenberg, N, et al.The psychological 
impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–920. 
 
Brown E, Gray R, Lo Monaco S, O'Donoghue B, Nelson B, Thompson A, Francey S, McGorry P. The 
potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic 
research. Schizophr Res. 2020 May 6:S0920-9964(20)30257-7. 
 
Chang SS, Stuckler S, Yip P, Gunnell D. Impact of 2008 global economic crisis on suicide: time trend 
study in 54 countries. BMJ 2013;347:f5239 doi: 10.1136/bmj.f5239 
 
Cheung YT, Chau PH, Yip PS. A revisit on older adults suicides and severe acute respiratory syndrome 
(SARS) epidemic in Hong Kong. Int J Geriatr Psychiatry 2008; 23: 1231–38. 
 
DeLeo D, Trabucchi M. COVID-19 and the fears of Italian senior citizens. Int J Environ Res Pub Health, 
18 May, 2020 DOI: 10.3390/ijerph17103572 
 
Deutsche Welle. Is social distancing during coronavirus causing more suicides? Accessed on June 3, 
2020. Available at: https://www.dw.com/en/is-social-distancing-during-coronavirus-causing-more-
suicides/a-53584282 
 
Devitt, P. (2020). Can We Expect an Increased Suicide Rate Due to Covid-19? Irish Journal of 
Psychological Medicine, 1-15. doi:10.1017/ipm.2020.46 
 
De Sousa A, Mohandas E, Javed A Psychological interventions during COVID-19: Challenges for low 
and middle income countries. Asian J Psychiatry 2020 https://doi.org/10.1016/j.ajp.2020.102128 
 




Gunnell D, Appleby L, Arensman E, Hawton K, John A, Kapur N. Suicide risk and prevention during the 
COVID-19 pandemic. The Lancet Psychiatry (in press). Doi: 10.1016/S2215-0366(20)30171-1. 
https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(20)30171-1/fulltext 
 
Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research 
priorities for the COVID-19 pandemic: a call for action for mental health science. The Lancet 








John A et al https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=183326 
 
Kawohl W, Nordt C. COVID-19, unemployment, and suicide. [correspondence]. The Lancet Psychiatry. 
Vol 7 May 2020; 389-90. 
 
Knipe D, Evans H, Marchant A, Gunnell D and John A. Mapping population mental health concerns 
related to COVID-19 and the consequences of physical distancing: a Google trends analysis. Available 
at: https://wellcomeopenresearch.org/articles/5-82/v1 
 
Liu Q, Luo D, Haase JE, Guo Q, Wang XQ, Liu S., et al. The experiences of health-care providers during 
the COVID-19 crisis in China: a qualitative study. Lancet Glob Health 2020; 8: e790–98 
Mars, B, Heron J, Klonsky ED . et al. Predictors of future suicide attempt among adolescents with 
suicidal thoughts or non-suicidal self- harm: a population- based birth cohort study. Lancet Psychiatry 
6, 327–337 (2019). 
 
May AM, Klonsky ED. What distinguishes suicide attempters from suicide ideators? A meta–analysis 
of potential factors. Clin Psychol 2016; 23: 5–20. 
 
14 
Mamun MA, Ullah I. COVID-19 suicides in Pakistan, dying off not COVID-19 fear but poverty?–The 
forthcoming economic challenges for a developing country. Brain, behavior, and immunity. 2020 May 
11. 
 
McIntyre RS, Lee Y. Preventing suicide in the context of the COVID-19 pandemic. World Psychiatry 
2020; 19: 250-251 https://onlinelibrary.wiley.com/doi/epdf/10.1002/wps.20767 
 
Moser DA, Glaus J, Frangou S, Schechter DS. Years of life lost due to the psychosocial consequences 
of COVID19 mitigation strategies based on Swiss data. medRxiv preprint doi: 
10.1101/2020.04.17.20069716.this version posted May 2, 2020. 
 
New Zealand Herald. Covid 19 coronavirus: Fewer suicides during lockdown level-4. Available at: 
https://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=12333030 
 
Norström T, Grönqvist H. The Great Recession, unemployment and suicide. J Epidemiol Community 
Health 2015;69:110–116. doi:10.1136/jech-2014-204602 
 
O’Connor, R.C., Hotopf, M., Worthman, C.M.,  Perry, V.H., Tracey, I., Wessely, S., Arseneault, L., 
Ballard, C., Christensen, H., Cohen Silver, R., Ford, T., John, A., Kabir, T., King, K., Simpson, A., Madan, 
I., Cowan, K., Bullmore, E.,  & Holmes, E.A. (in press).  Multidisciplinary research priorities for the 
COVID-19 pandemic: authors' reply. Lancet Psychiatry. 
 
Pierce M, McManus S, Jessop C, John A, Hotopf M, Ford T, et al. Says who? The significance of 
sampling in mental health surveys during COVID-19. Lancet Psychiatry 2020, Published Online June 2, 
2020 https://doi.org/10.1016/ S2215-0366(20)30237-6 
 
Reger MA, Stanley IH, Joiner TW. Suicide Mortality and Coronavirus Disease 2019—A Perfect Storm? 
JAMA Psychiatry. Published online April 10, 2020. doi:10.1001/jamapsychiatry.2020.1060 
 
Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G. 
Anthony S David Psychiatric and neuropsychiatric presentations associated with severe coronavirus 
infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. 




Royal College of Psychiatrists. Psychiatrists see alarming rise in patients needing urgent and 




Sinyor M, Spittal MJ, Niederkrotenthaler T. Changes in Suicide and Resilience-Related Google 
Searches during the Early Stages of the COVID-19 Pandemic. Canadian Journal of Psychiatry (in 
press). 
 




Torjesen I. Covid-19: Doctors need proper mental health support, says BMA. BMJ 2020;369:m2192 
doi: 10.1136/bmj.m2192 (Published 1 June 2020) 
 
 
Townsend E, Nielsen E, Allister R, Cassidy SA. Key ethical questions for research during the COVID-19 
pandemic. Lancet Psychiatry 2020; https://www.thelancet.com/journals/lanpsy/article/PIIS2215-
0366(20)30150-4/fulltext  
 
Tran US, Andel R, Niederkrotenthaler T, Till B, Ajdacic-Gross V, Voracek M (2017). Low validity of 
Google Trends for behavioral forecasting of national suicide rates. PLoSONE 12(8):e0183149. 
doi.org/10.1371/journal.pone.0183149 
 
United Nations. 2020a. Policy Brief: COVID-19 and the Need for Action on Mental Health. 
https://www.un.org/sites/un2.un.org/files/un_policy_brief-covid_and_mental_health_final.pdf 
 
United Nations. 2020b. UN chief calls for ‘solidarity, unity and hope’ in battling COVID-19 pandemic- 
Available at: https://news.un.org/en/story/2020/04/1062972 
 
16 
Van Bavel JJ, et a. Using social and behavioral science to support COVID-19 pandemic response. 
Nature Human Behavior 2020;4:460–471. 
 
Wand APF, Zhong BL, Chiu HFK, Draper B, De Leo D. COVID-19: the implications for suicide in older 
adults. Int Psychogeriatr. 2020 Apr 30 : 1–6. Published online 2020 Apr 30. doi: 
10.1017/S1041610220000770 
 
Wasserman IM. The impact of epidemic, war, prohibition and media on suicide: United States, 1910–
1920. Suicide Life Threat Behav 1992; 22: 240–54.  
 
Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C. Nervous System Involvement After 
Infection With COVID-19 and Other Coronaviruses. Brain Behav Immun 2020 Mar 30. 
https://www.sciencedirect.com/science/article/pii/S0889159120303573?via%3Dihub 
 
World Health Organization. (2014). Preventing suicide: A global imperative. Geneva, Switzerland: 
 
World Health Organization. (2016). Practice manual for establishing and maintaining surveillance 





Yao H, Chen JH, Xu YF (2020). Patients with mental health disorders in the COVID-19 epidemic. The 
Lancet. Psychiatry; 7(4), e21. https://doi.org/10.1016/S2215-0366(20)30090-0 
 
Yip, PSF, Chau PH  Physical Distancing and Emotional Closeness Amidst Covid-19  Crisis, 2020, 
Editorial.  https://doi.org/10/1027/0227-5910/a000710 
 
17 
Zhang  C,  Shi  L, Wang FS. Liver Injury in COVID-19: Management and Challenges. Lancet 
Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 
Mar 4.  
 
 
Zortea, T.C., Brenna, C.T.A., Joyce, M., McClelland, H., Tippett, M., Tran, M. Arensman, E., Corcoran, 
P., Hatcher, S., Heisel, M.J., Links, P.D., O'Connor, R.C., Edgar, N.E., Cha, Y., Guaiana, G., Williamson, 
E., Sinyor, M., & Platt, S. (2020).  The impact of infectious disease-related public health emergencies 











Box 2: Example research questions relating to whether rates of suicide and/or suicidal behavior 



















Time What is the impact of the pandemic on suicide and suicidal behavior and does risk 
differ over its course and in its aftermath? 
Place Are there underlying country- or region-level differences that may explain variable 
changes in rates of suicide and suicidal behavior? For example, do the background 
rates of suicide and suicidal behavior seem to have a bearing on any increases? 
What about the number of Covid-19 cases and deaths, the capacity of the healthcare 
system, and the pandemic response? And are any observed relationships the same 
for low and middle income countries as they are for high income countries? 
Person Does any change in the incidence of suicide and suicidal behavior and specific 
suicide methods vary by population subgroup? For example, is there variation by 
demographic factors (e.g., age, gender, ethnicity, religious affiliation), household 
structure (e.g., living alone, living with children, living with joint/extended 
families), socio-economic factors (e.g., socio-economic status, job loss, financial 











Risk factors Are there recognised risk factors for suicide and suicidal behavior that are 
heightened during the pandemic that might explain any increases? For example, 
how do any changes in suicide and suicidal behavior relate to changes in levels of 
anxiety, depression, alcohol use or feelings of entrapment that might be increased 
by isolation, loneliness, uncertainty, domestic violence, economic hardship and 
reduced social participation? 
Protective 
factors 
Are there recognised protective factors for suicide and suicidal behavior that might 
be bolstered during the pandemic and potentially keep rates of suicide and suicidal 
behavior from increasing? For example, if communities rally around and provide 
support for those who might be vulnerable, does this have a positive impact? 
New factors Are there new risk or protective factors for suicide and suicidal behavior that 
correspond to the emergence of the pandemic? And are there risk or protective 
factors that have been exacerbated or changed in importance? For example, has 
face-to-face and online racism against Asian people during the pandemic led to an 








Have changes in access to the means of suicide resulted in changes to methods used 
and affected rates of suicide and suicidal behavior? For example, have suicide by 
firearms, pesticides and medications increased as a result of people stockpiling 
these? And have rail suicides decreased due to travel restrictions? 
Media 
reporting 
How does the media report on Covid-19 and on Covid-19-related suicides, and 
what is the impact of this reporting on suicide and suicidal behavior? For example, 






Have patterns of social media usage/consumption and other online activity changed 
during the pandemic, and, if so, is this associated with suicidal behavior? For 
example, does repeated exposure to information about the pandemic heighten fear 
and increase the risk of suicide and suicidal behavior? Or does the connectedness 




Has the pandemic changed the way we live and behave, or will it do so in the 
future? If so, which changes are beneficial and which are harmful with respect to 

























Do people who may be particularly vulnerable to Covid-19 (e.g., older people, 
those living with chronic conditions or other medical complications) have elevated 
risk of suicide and suicidal behavior? 
Covid-19 
Infected 
Are people who are recovering or have recovered from Covid-19 at increased risk 
of suicidal behavior? Are there neurobiological mechanisms that mediate any 
increased risk for these people? Are people experiencing longer-term physical 




Is there an increased risk of suicide and suicidal behavior among frontline health 
and social care staff who are looking after Covid-19 patients? If so, is this risk 
associated with exposure to the virus, loss and grief, ethical challenges of having to 









Has the risk of suicide and suicidal behavior increased for people with pre-existing 
mental health problems? 
Suicide 
attempters 
Are there increased numbers of people who make suicide attempts without 
presenting to hospital? 
Economicall
y affected 
and high risk 
occupational 
groups 
Are people whose economic circumstances have been adversely affected by the 
pandemic (e.g., those who have lost their jobs, those whose businesses have folded) 
at increased risk of suicide and suicidal behavior? What is the impact of Covid-19 
on suicide and suicidal behavior in different occupational groups, e.g. healthcare 





Are children and adolescents at increased risk of suicidal behavior as a result of 
factors like changes to their educational and vocational opportunities and reduced 
face-to-face contact with their peers? Are there particularly sensitive developmental 
stages or ages where interruptions will have the greatest impact on suicide and 
suicidal behavior in adulthood? What is the impact of Covid-19 on trends in suicide 
and suicidal behavior among children, adolescents and young adults, taking into 
account countries which observed increasing trends in suicide attempt and suicide 
in young people pre-Covid-19? 
Older people Are older people at increased risk? What are the impacts of bereavement, 
loneliness, vulnerability to Covid-19 and stigma? Do living arrangements (e.g., 




Is there an increased risk of suicide and suicidal behavior for migrants who may be 
living without a job in their host country or being forced to return to their native 
country? And what about refugees and displaced people living in camps with 
limited access to support or care? Are there differences between migrant groups 
and are refugees, asylum seekers and irregular migrants at increased risk of suicidal 
behavior? 
 
Box 3: Example research questions relating to whether particular approaches/responses might 
help to mitigate any risk of suicide and/or suicidal behavior associated with the pandemic 
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